Search -

Displaying 221 - 240 of 323

Sort: Relevancy | Date

Presentation TCT 2016

When Is Pacing Needed in HCM Outside Invasive Management Settings

Presenter: Bernard J. Gersh, Harry Rakowski

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

Presentation TCT 2016

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

Presentation TCT 2016

Cardiac MR for Diagnosis and Guiding Management of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai

October 30, 2016

Presentation TCT 2016

Echocardiography Essentials for Comprehensive Evaluation of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

News Industry News

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

August 31, 2016

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

Presentation TVT 2016

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

Presenter: Chet Rihal

June 17, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Michael O'Riordan

April 22, 2016

News Conference News ACC 2016

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Michael O'Riordan

April 06, 2016

Presentation ECHO 2016

Hypertrophic Cardiomyopathy: Diagnosis and Management

Presenter: Gerard P. Aurigemma

March 21, 2016

Presentation TCT 2015

Heart Block at Day 3 After Alcohol Septal Ablation. What to Do Now?

Presenter: Dominique Himbert, Paul Sorajja, John C. Messenger

October 15, 2015

Presentation TCT 2015

Alcohol Septal Ablation: My Worst Complication (and What I Wish I Did Differently)

Presenter: Dominique Himbert, Paul Sorajja, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

Who to Restrict for Athletic Participation

Presenter: Dominique Himbert, Paul Sorajja

October 15, 2015

Presentation TCT 2015

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Should Be Offered to Elderly Patients Only!

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 15, 2015

Presentation TCT 2015

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Is Equally Effective at All Ages!

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 15, 2015

Advertisement

When Is Pacing Needed in HCM Outside Invasive Management Settings

Medical Management of Non-Obstructive HCM: When and Which Medications?

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Cardiac MR for Diagnosis and Guiding Management of HCM

Echocardiography Essentials for Comprehensive Evaluation of HCM

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

AS and the Patient With Hypertrophic Cardiomyopathy (With and Without Obstruction)

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Evidence Does Not Support Widespread Preparticipation ECG Screening in Young Athletes

Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon

Hypertrophic Cardiomyopathy: Diagnosis and Management

Heart Block at Day 3 After Alcohol Septal Ablation. What to Do Now?

Alcohol Septal Ablation: My Worst Complication (and What I Wish I Did Differently)

Who to Restrict for Athletic Participation

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Should Be Offered to Elderly Patients Only!

Debate 3: Which Age Group Should Be Referred for Alcohol Septal Ablation? The Procedure Is Equally Effective at All Ages!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content